Global CD137 Antibody Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global CD137 Antibody market size was valued at US$ 507 million in 2024 and is forecast to a readjusted size of USD 1120 million by 2031 with a CAGR of 12.1% during review period.

CD137 Antibody is an antibody directed against the CD137 (also known as 4-1BB) protein in the human immune system.

CD137 is a cell surface molecule that belongs to the tumor necrosis factor receptor superfamily and is mainly expressed on activated T cells, natural killer cells and certain antigen-presenting cells. After binding to its ligand, CD137 can promote the proliferation, survival and cytotoxic response of T cells, thereby enhancing the immune response. Combining CD137 antibody with CD137 molecule may have a potential role in immunotherapy, which can be used to enhance anti-tumor immune response and treat diseases such as infection and tumor. Therefore, CD137 antibodies have attracted much attention in immunotherapy research and are regarded as one of the potential therapeutic strategies.

This report is a detailed and comprehensive analysis for global CD137 Antibody market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global CD137 Antibody market size and forecasts, in consumption value ($ Million), 2020-2031

Global CD137 Antibody market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global CD137 Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global CD137 Antibody market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for CD137 Antibody

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global CD137 Antibody market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sino Biological, Inc., Thermo Fisher, LifeSpan BioSciences, Inc, BioLegend, Abcam, Bio-Techne, GeneTex, Bio-Rad Laboratories, Inc., Arigo Biolaboratories Corp., Merck, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

CD137 Antibody market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Monoclonal Antibody

Polyclonal Antibody

Market segment by Application

Flow Cytometry

ELISA

Immunoprecipitation

Others

Market segment by players, this report covers

Sino Biological, Inc.

Thermo Fisher

LifeSpan BioSciences, Inc

BioLegend

Abcam

Bio-Techne

GeneTex

Bio-Rad Laboratories, Inc.

Arigo Biolaboratories Corp.

Merck

Cell Signaling Technology, Inc.

MyBiosource, Inc.

Boster Biological Technology

Biocare Medical, LLC

Signalway Antibody LLC

NSJ Bioreagents

Leinco Technologies

Wuhan Fine Biotech Co., Ltd.

Elabscience Biotechnology Inc.

Biotium

Bioss Inc

Miltenyi Biotec

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe CD137 Antibody product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of CD137 Antibody, with revenue, gross margin, and global market share of CD137 Antibody from 2020 to 2025.

Chapter 3, the CD137 Antibody competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and CD137 Antibody market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of CD137 Antibody.

Chapter 13, to describe CD137 Antibody research findings and conclusion.